Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 29.16% is 186% above its 5-year average of -33.80%, near the high end of its 5-year range (-114.21%–48.27%).
1800.29% above its 12-month average of -1.71%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -7.72%.
RETURN ON ASSETS (ROA)
29.16%
RETURN ON ASSETS (ROA) AVG TTM
-1.71%
RETURN ON ASSETS (ROA) AVG 3Y
-34.07%
RETURN ON ASSETS (ROA) AVG 5Y
-33.80%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+1800.29%
CURRENT VS 3Y AVG
+185.58%
CURRENT VS 5Y AVG
+186.26%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.27%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
+190.38%
vs the sector median at left
Q32 Bio Inc.
Market Cap
$241.39M
Return on Assets (ROA)
29.16%
TTM Avg
-1.71%
3Y Avg
-34.07%
5Y Avg
-33.80%
Market Cap
$241.34M
Return on Assets (ROA)
-50.89%
TTM Avg
-41.00%
3Y Avg
-37.00%
5Y Avg
-42.85%
Market Cap
$241.94M
Return on Assets (ROA)
N/A
TTM Avg
-14.72%
3Y Avg
-16.00%
5Y Avg
-18.82%
Market Cap
$239.02M
Return on Assets (ROA)
-38.25%
TTM Avg
-20.05%
3Y Avg
-26.23%
5Y Avg
-29.50%
Market Cap
$239.01M
Return on Assets (ROA)
-8.99%
TTM Avg
-7.90%
3Y Avg
-14.69%
5Y Avg
-13.78%
Market Cap
$237.57M
Return on Assets (ROA)
-49.04%
TTM Avg
-75.08%
3Y Avg
-74.95%
5Y Avg
-71.96%
Market Cap
$236.82M
Return on Assets (ROA)
-23.80%
TTM Avg
-23.59%
3Y Avg
-108.30%
5Y Avg
-108.30%
Market Cap
$235.97M
Return on Assets (ROA)
-1.57%
TTM Avg
17.43%
3Y Avg
19.75%
5Y Avg
24.82%
Market Cap
$235.66M
Return on Assets (ROA)
-8.48%
TTM Avg
-16.43%
3Y Avg
-20.20%
5Y Avg
-32.31%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Q32 Bio Inc. (QTTB) | $241.39M | 29.16% | -1.71% | -34.07% | -33.80% |
| Quantum-Si incorporated (QSI)vs › | $241.34M | -50.89% | -41.00% | -37.00% | -42.85% |
| Lifecore Biomedical, Inc. (LFCR)vs › | $241.94M | N/A | -14.72% | -16.00% | -18.82% |
| Century Therapeutics, Inc. (IPSC)vs › | $239.02M | -38.25% | -20.05% | -26.23% | -29.50% |
| High Tide Inc. (HITI)vs › | $239.01M | -8.99% | -7.90% | -14.69% | -13.78% |
| Invivyd, Inc. (IVVD)vs › | $237.57M | -49.04% | -75.08% | -74.95% | -71.96% |
| BioAge Labs Inc. (BIOA)vs › | $236.82M | -23.80% | -23.59% | -108.30% | -108.30% |
| SIGA Technologies, Inc. (SIGA)vs › | $235.97M | -1.57% | 17.43% | 19.75% | 24.82% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $235.66M | -8.48% | -16.43% | -20.20% | -32.31% |
| Sol-Gel Technologies Ltd. (SLGL)vs › | $247.27M | -30.39% | -25.00% | -35.54% | -31.17% |
ROA
29.2%
ROE
31.9%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 48.27% |
| 2024-12-31 | -51.70% |
| 2023-12-31 | -114.21% |
| 2022-12-31 | -18.65% |
| 2021-12-31 | -17.74% |
| 2020-12-31 | -48.80% |
| 2019-12-31 | -33.46% |
| 2018-12-31 | -21.45% |
| 2017-12-31 | -21.81% |
| 2016-12-31 | -56.59% |
